In Nature this week, work led by Duke's David Goldstein used a GWAS to show that a SNP (rs12979860) three kilobases upstream of the IL28B gene, which encodes the type III interferon IFN-lambda3, strongly associates with more than a two-fold difference in response to hepatitis C virus drug treatment in both European-Americans and African-Americans.